BACKGROUND: Social withdrawal is a core neuropsychiatric phenomenon in developmental psychopathology. Its presence predicts psychopathology across many domains, including depression, psychosis, autism, anxiety, and suicide. Withdrawn behavior is highly heritable, persistent, and characteristically worsens without intervention. To date, few studies have successfully identified genetic associations with withdrawn behavior, despite the abundance of evidence of its heritability. This may be due to reliance of categorical over dimensional measures of the behaviorally inhibited phenotype. The aim of this study is to identify associations between known psychiatric candidate genes and a dimensionally derived measure of withdrawn behavior. METHODS: Genetic information was collected on 20 single-nucleotide polymorphisms (SNPs) from a custom-designed SNP chip and TAQMAN arrays of 4 variable number of tandem repeat (VNTR) genes for 551 individuals from 187 families. Linear mixed modeling was employed to examine the relationship between genotypes of interest and Child Behavior Checklist (CBCL) Withdrawn Behavior Subscale Score (WBS) while controlling for gender and age through multiple linear regressions. RESULTS: Withdrawn behavior was highly associated with polymorphism rs6314 of the serotonin receptor 2A (HTR2A) [p = .009, estimate = 0.310 (bootstrap 95% CI 0.155-0.448), bootstrap p = .001] and rs1800544 of the alpha 2-adrenergic (ADRA2A) [p = .001, estimate = -0.310 (bootstrap 95% CI -0.479 to -0.126), bootstrap p = .001] genes after correction for gender and age. The association between withdrawn behavior and ADRA2A was stronger for younger children. CONCLUSIONS: HTR2A and ADRA2A genes are associated with withdrawn behavior. This reinforces the role of catecholaminergic genes in the heritability of withdrawn behavior.
BACKGROUND: Social withdrawal is a core neuropsychiatric phenomenon in developmental psychopathology. Its presence predicts psychopathology across many domains, including depression, psychosis, autism, anxiety, and suicide. Withdrawn behavior is highly heritable, persistent, and characteristically worsens without intervention. To date, few studies have successfully identified genetic associations with withdrawn behavior, despite the abundance of evidence of its heritability. This may be due to reliance of categorical over dimensional measures of the behaviorally inhibited phenotype. The aim of this study is to identify associations between known psychiatric candidate genes and a dimensionally derived measure of withdrawn behavior. METHODS: Genetic information was collected on 20 single-nucleotide polymorphisms (SNPs) from a custom-designed SNP chip and TAQMAN arrays of 4 variable number of tandem repeat (VNTR) genes for 551 individuals from 187 families. Linear mixed modeling was employed to examine the relationship between genotypes of interest and Child Behavior Checklist (CBCL) Withdrawn Behavior Subscale Score (WBS) while controlling for gender and age through multiple linear regressions. RESULTS: Withdrawn behavior was highly associated with polymorphism rs6314 of the serotonin receptor 2A (HTR2A) [p = .009, estimate = 0.310 (bootstrap 95% CI 0.155-0.448), bootstrap p = .001] and rs1800544 of the alpha 2-adrenergic (ADRA2A) [p = .001, estimate = -0.310 (bootstrap 95% CI -0.479 to -0.126), bootstrap p = .001] genes after correction for gender and age. The association between withdrawn behavior and ADRA2A was stronger for younger children. CONCLUSIONS:HTR2A and ADRA2A genes are associated with withdrawn behavior. This reinforces the role of catecholaminergic genes in the heritability of withdrawn behavior.
Authors: Caio Cesar Silva de Cerqueira; Evelise Regina Polina; Verônica Contini; Francine Zanquetta Coelho Marques; Eugenio Horacio Grevet; Carlos Alberto Iglesias Salgado; Paula Oliveira Guimarães da Silva; Felipe Almeida Picon; Paulo Belmonte-de-Abreu; Claiton Henrique Dotto Bau Journal: Psychiatry Res Date: 2010-09-22 Impact factor: 3.222
Authors: Toshiaki Onitsuka; Martha E Shenton; Dean F Salisbury; Chandlee C Dickey; Kiyoto Kasai; Sarah K Toner; Melissa Frumin; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley Journal: Am J Psychiatry Date: 2004-09 Impact factor: 18.112
Authors: Ayman H Fanous; M C Neale; R E Straub; B T Webb; A F O'Neill; D Walsh; K S Kendler Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2004-02-15 Impact factor: 3.568
Authors: I Mata; M J Arranz; A Patiño; T Lai; M Beperet; L Sierrasesumaga; D Clark; F Perez-Nievas; L Richards; F Ortuño; P Sham; R W Kerwin Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2004-04-01 Impact factor: 3.568
Authors: Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould Journal: Neuropharmacology Date: 2014-11-04 Impact factor: 5.250
Authors: Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2016-05-19 Impact factor: 3.568
Authors: Sarah D Linnstaedt; Margaret G Walker; Kyle D Riker; Jennifer E Nyland; JunMei Hu; Catherine Rossi; Robert A Swor; Jeffrey S Jones; Luda Diatchenko; Andrey V Bortsov; David A Peak; Samuel A McLean Journal: Pain Date: 2017-02 Impact factor: 7.926
Authors: Anna Morozova; Yana Zorkina; Konstantin Pavlov; Olga Pavlova; Zinaida Storozheva; Eugene Zubkov; Natalia Zakharova; Olga Karpenko; Alexander Reznik; Vladimir Chekhonin; Georgiy Kostyuk Journal: Front Psychiatry Date: 2019-11-12 Impact factor: 4.157